Profile
Daniel Lasanow currently works at Polypeptide Laboratories France SAS, as Chairman from 2017.
Mr. Lasanow also formerly worked at Lonza, Inc., as Production Director, NextPharma Technologies SA (Belgium), as Production Director from 2009 to 2011, UCB-Bioproducts SA, as Production Director, and PolyPeptide Group AG, as Director-Global Operations from 2016 to 2022.
Mr. Lasanow received his graduate degree from Université Catholique de Louvain.
Daniel Lasanow active positions
| Companies | Position | Start |
|---|---|---|
Polypeptide Laboratories France SAS
Polypeptide Laboratories France SAS Chemicals: SpecialtyProcess Industries Operates as a contract manufacturer of organic peptides | Chairman | 2017-04-09 |
Former positions of Daniel Lasanow
| Companies | Position | End |
|---|---|---|
| POLYPEPTIDE GROUP AG | Chief Operating Officer | 2022-11-29 |
NextPharma Technologies SA (Belgium) | Corporate Officer/Principal | 2010-12-31 |
UCB-Bioproducts SA
UCB-Bioproducts SA Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of pharmaceuticals | Corporate Officer/Principal | - |
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Provides chemical ingredient products | Corporate Officer/Principal | - |
Training of Daniel Lasanow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Lonza, Inc.
Lonza, Inc. Chemicals: SpecialtyProcess Industries Provides chemical ingredient products | Process Industries |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextPharma Technologies SA (Belgium) | |
UCB-Bioproducts SA
UCB-Bioproducts SA Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of pharmaceuticals | Commercial Services |
Polypeptide Laboratories France SAS
Polypeptide Laboratories France SAS Chemicals: SpecialtyProcess Industries Operates as a contract manufacturer of organic peptides | Process Industries |
PolyPeptide Group AG
PolyPeptide Group AG BiotechnologyHealth Technology Manufactures polypeptide and custom peptide synthesis | Health Technology |
- Stock Market
- Insiders
- Daniel Lasanow
















